Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Lam Research (LRCX, NASDAQ): To the Insiders -- Ignore unavailable to you. Want to Upgrade?

To: Proud_Infidel who wrote (3285)	9/2/1999 9:04:00 AM
From: Duker	Read Replies (1) \| Respond to of 5867

Tegal Files Patent Infringement Suit Against Lam Research [Well alright, a patent infringement suit. The home team must be doing something right! --Duker] ALEXANDRIA, Va. (Dow Jones)--Tegal Corp. (TGAL) filed a patent infringement suit in U.S. District Court, Eastern District of Virginia, against Lam Research Corp. (LRCX). In a press release Thursday, Tegal said the suit alleges that Lam deliberately infringed two Tegal patents in developing its Exelan system. Officials for Lam, based in Fremont, Calif., were not immediately available for comment. The patents cover Tegal's dual-frequency triode method for plasma etching and Tegal's dual-frequency diode plasma apparatus, Tegal said. Tegal, a Petaluma, Calif., maker of plasma-etch systems, said the suit seeks treble damages, attorney fees and other costs. Tegal said the court awarded it attorney fees and costs and enjoined Lam, a semiconductor maker, from further infringement of one of the two patents. -Dave Copeland; 201-938-5400